Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents $ 563 $ 2,361
Restricted cash 1,518 173
Accounts receivable, net 5,629 5,824
Inventories, net 5,122 6,580
Prepaid expenses and other current assets 2,005 2,641
Total Current Assets 14,837 17,579
Property and equipment, net 305 417
Right-of-use assets, operating leases 718 951
Intangible assets, net 13,496 14,641
Goodwill 18,614 18,614
Other assets 1,876 1,330
Total Assets 49,846 53,532
Current Liabilities    
Short term loan, net 19,369 16,061
Line of credit, net 0 4,819
PPP loans 458 0
Other liabilities 1,727 500
Accounts payable 4,090 4,049
Accrued liabilities 5,371 4,721
Deferred revenue 305 311
Operating lease liability, current portion 395 345
Warrant derivative liability 102 2,220
Total Current Liabilities 31,817 33,026
Non-current Liabilities    
Notes payable, net 18,240 16,370
Line of credit, net 5,048 0
PPP loans 394 0
Operating lease liability 350 641
Total Non-current Liabilities 24,032 17,011
Total Liabilities 55,849 50,037
Redeemable Series E Convertible Preferred Stock    
Redeemable Series E preferred stock, $0.001 par value, 2,900,000 shares authorized, 1,387,378 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 10,566 10,566
Stockholders’ Deficit    
Common stock, $0.001 par value, 200,000,000 and 88,000,000 shares authorized as of September 30, 2020 and December 31, 2019, respectively, and 49,139,708 and 47,977,390 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 49 48
Additional paid-in capital 214,305 194,150
Accumulated deficit (230,923) (201,269)
Total Stockholders’ Deficit (16,569) (7,071)
Total Liabilities, Redeemable Preferred Stock, and Stockholders’ Deficit $ 49,846 $ 53,532